drugset / Trial / NCT00296686

Sequential Tranylcypromine (TC), TC + Dextroamphetamine and TC + Triiodothyronine for Refractory Depression

NCT00296686 ↗

Phase 4 Terminated 31 enrolled New York State Psychiatric Institute
NaSingle-groupOpen-labelTreatment

Summary

This pilot study will assess the efficacy of several sequential pharmacological treatments for patients with Refractory Depression.

Timeline

Start
2001-09
Primary completion
2006-08
Completion
2006-08

Outcome

Outcome not reported

Stopped (Business): “Study is no longer funded.”

Drugs

EvaluationDrugModalityDoseRoute
Subject Dextroamphetamine Small molecule 40 mg —
Subject Tranylcypromine Small molecule 60 mg —
Subject Tranylcypromine Small molecule 120 mg —
Subject triiodothyronine Unknown 75 mg —